Nikolai Petrovsky MBBS, FRACP, PhD is an active hospital clinician, research professor at Flinders Medical Centre, Adelaide Australia and research director of Vaxine, an Australian vaccine development company. He is Secretary-General of the International Immunomics Society and has received major funding from the US National Institutes of Health to develop novel biodefense vaccines and adjuvants. He has won prestigious awards including the AMP Innovation Award at the 2009 Telstra Business Awards and an Ernst & Young Entrepreneur of the Year in 2010. He has taken four vaccines to the clinic and has authored over 100 scientific papers and book chapters.

Vaccines

Dr. Diane Medved Harper is a Professor of Medicine in the departments of Obstetrics and Gynecology, Community and Family Medicine and Informatic Medicine and Persionalized Health at the University of Missouri-Kansas City School of Medicine.  Dr. Harper completed her undergraduate and graduate degrees at the Massachusetts Institute of Technology in Boston, Massachusetts, in the fields of Chemical Engineering and Polymerics.  She received her medical degree from the University of Kansas in Kansas City, where she also did residencies in Ob/Gyn and Family Medicine.  She attended Stanford University and Harvard University for her training in medical decision making and cost effectiveness analysis as part of her Public Health degree.  Dr. Harper developed the Gynecologic Cancer Prevention Research Group during her tenure at Dartmouth Medical School bringing this research expertise to UMKC. She is an internationally recognized expert on HPV vaccines having worked with both Merck and GSK to develop Gardasil and Cervarix in phase II and phase III trials.  She has published the sentinel work on both vaccines and is an on call consultant to WHO for HPV vaccine policy in developing countries.  She has been instrumental in guiding the course of HPV vaccination around the world.  Dr. Harper has been honored by her peers as both the New Hampshire physician of the year in 2006 and multiple times as teacher of the year. She has over 100 peer reviewed publications and sits on more than 10 journal editorial boards.

Cervical Cancer Prevention, HPV vaccines.

Nizar Souayah is an Assistant Professor of Neurology at New Jersey Medical School.He is Director of EMG LAB Peripheral Neuropathy Center. He graduated with an MD 20 years ago.

Neurology

Tumor Immunology
Molecular Biology.

Robert Martin Jacobson born September 20, 1958 is the chair of the Department of Pediatric and Adolescent Medicine at the Mayo Clinic and a full professor of pediatrics at the Mayo Medical School in Rochester. He received his BSc in Chemistry in 1980 from Butler University also in Indianapolis. Besides administrative responsibilities related to being chair he regularly sees young patients as a member of the Division of Community Pediatric and Adolescent Medicine. His research area is in vaccinology with a focus on delivery effectiveness and adverse consequences Jacobson coleads the Vaccine Research Group at the Mayo Clinic with Greg Poland. He is also involved with the Clinical Research Training Program in the Mayo Medical School.

Immunization and epidemiology continue to be a focus in his current research which includes the genetic basis for vaccine response towards measles, mumps and rubella. His research group also focuses on anthrax and smallpox vaccines, which are directed against bioterrorism.

Larry W Kwak is a Professor in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine at the University of Texas-Houston. He graduated 1984 from Northwestern University Graduate School, Evanston.

Cancer Immunology

David Scott McVey is now at the University of Nebraska, where he is Professor of Clinical Microbiology and Director of the Veterinary Diagnostic Center. He supervises diagnostic bacteriology and teaches bacteriology in the University of Nebraska-Iowa State University joint program for veterinary medicine. Dr. McVey was recipient of the Distinguished Alumni Award from the University of Tennessee College of Veterinary Medicine in 2007. He also is a past President and currently president-elect of the American College of Veterinary Microbiologists and has also a served on the Blue Ribbon Panel for Counter Measures for Terrorist Threats to Agriculture for the President of the United States.  Dr. McVey is the author of over 50 research articles, book chapters and patents as well as numerous abstracts and reports. He is serving as an editorial board member and reviewer of 5 journals.

Respiratory diseases of cattle
Infectious bovine keratitis
Vaccines and anti-infective therapeutics for cattle
Diagnostic microbiology.

Chinnaswamy Jagannath is a professor of pediatrics in division of pediatric infectious diseases. He is also serves as assistant dean for academic and faculty affairs. He is peer reviewer of more than 35 articles.

The major focus of my laboratory is on vaccine development for tuberculosis. Tuberculosis is the leading cause of death due to infections in the world today and we are working on newer strategies to develop vaccines. We developed a novel gene knockout vaccine from Mycobacterium tuberculosis (Mtb) that protects mice better than BCG (Infection& Immunity, 2000, 2004). We propose to develop this ultimately into a candidate vaccine for humans. Although BCG is used a vaccine against tuberculosis in man, it does not offer long term protection. Parameters for long term immunity are uncertain. However, a key defect in development of better vaccine effect is that both BCG and wild type Mtb inhibit phagosome maturation, lysosomal degradation and processing of antigens through MHC pathway so that effective T cell responses are probably not induced. We have therefore developed novel hypotheses and mechanisms to address this issue.

Dr. Anthony Confer received his DVM degree from Oklahoma State University in 1972, his MS in Veterinary Pathology from Ohio State in 1974, and his PhD degree in Microbiology from the University of Missouri in 1978.  He is a Diplomate of the American College of Veterinary Pathologists.  He has been on faculty at Oklahoma State University, Center for Veterinary Health Sciences since 1981 and is currently Regents Professor & Sitlington Endowed Chair for Food Animal Research.  He teaches veterinary and graduate students in the fields of pathology and infectious diseases, provides diagnostic pathology support for clinical cases and research, and is the Project Director for the Bovine Respiratory Disease Research Unit.  Dr. Confer served as Department Head from 1986 to 1999 & from 2004 to 2008 and as Associate Dean for Research from 1999 to 2001. His research and expertise are in immunity to Mannheimia haemolytica and Pasteurella multocida in cattle, and he has been an invited speaker internationally in the areas of bovine respiratory disease and immunity to Gram-negative pathogens. His research has been continuously supported by numerous grants from the USDA, animal health companies, and private foundations. He has served on the editorial boards of Veterinary Pathology and American Journal of Veterinary Research. He has authored 195 peer-reviewed scientific manuscripts, 12 book chapters, 4 education journal articles, 116 published abstracts, and 12 continuing education articles.  He is a member of the American College of Veterinary Pathologists, American Society of Microbiology, Conference of Research Workers in Animal Diseases, and the Veterinary Comparative Respiratory Society. His honors include Distinguished Alumnus – OSU College of Veterinary Medicine (2009), Regents Distinguished Teaching Award (2008), Oklahoma State University Eminent Faculty Award (2003), promoted to Regents Professor (2003), and Norden Distinguished Teacher Award (1987, 2002).

Role of outer membrane proteins in stimulating immunity against Gram – negative bacteria, Molecular approaches to vaccination against bovine respiratory diseases.
 

Dr. Chatterjee is Professor of Pediatrics and Medical Microbiology and Immunology at Creighton University and Adjunct Professor Clinical of Pediatrics at the University of Nebraska College of Medicine in Omaha Nebraska. She is also the Hospital Epidemiologist at Children’s Hospital in Omaha. Dr Chatterjee was born in India and attended high school at the Army Public School in New Delhi India. She received her MBBS MD from the Armed Forces Medical College at Pune University in India. Dr Chatterjee earned her PhD at the University of Nebraska Medical Center in Omaha Nebraska and conducted postdoctoral research in neonatology at the University of Nebraska Medical Center. She completed her residency in pediatrics followed by Pediatric Infectious Diseases Fellowship training at Creighton University/University of Nebraska Medical Center in Omaha. Dr Chatterjee has received numerous research awards.

Her research interests include vaccine development for Human Papilloma Viruses, other pediatric vaccines, hospital epidemiology, community-acquired methicillin-resistant Staphylococcus aureus, inhibition of H. pylori by nutraceuticals and antibiotic resistance.

Vaccines.

Toshi Nagata is a professor of Department of Health Science, Hamamatsu University School of Medicine, Hamamatsu, Japan. He has received a PhD in molecular biology in Osaka University, Osaka, Japan in 1989. He had his postdoctoral training during 19891992 at National Institute of Child Health and Human Development NICHD, National Institutes of Health NIH, Bethesda, USA. Then, he was an assistant professor at Department of Parasitology, Yokohama City University, Yokohama, Japan during 1995-1997. Then, he was an associate professor at Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Hamamatsu, Japan during 1997-2006. Since then, he has been a professor of Department of Health Science, Hamamatsu University School of Medicine, Hamamatsu, Japan. He is serving as a reviewer of many reputed journals on immunology and microbiology, etc.

T-cell responses against intracellular pathogens DNA vaccination Antigen presentation Genetics of MHC molecules

Janet McElhaney Professor in Department of Medicine at University of British Columbia, Canada and serving as Regional Medical Director.

I am part of a research team focused on developing interventions that identify and minimize risk for catastrophic disability and promote healthy aging in older adults. The objectives are to determine which inflammatory markers predict catastrophic disability, relate these markers to other identified risk factors, and develop targeted, effective interventions.

It is worth mentioning that Dr. Mohamed Labib was born in the village Dhtora Zefta Center; Gharbia in 1962 Married and has two sons and a daughter received a Bachelor of Science from the University of Tanta in 1984 and doctoral degrees in 1995 he belongs to the scientific school in the field of Immunology and Oncology Supervised Many of the scientific researchers at Tanta University and many universities in the United States of America a member of several scientific societies organs such as the US association of Immunology and Scientific Assembly in oncology international arbitrator a member of the committees for publication of many scientific journals a member in the jury of faculty at the Republic in the field of basic science and also a member in the Advisory Committee of the National Authority for Quality and Accreditation of Republic education

Immunology and Oncology

Acquisition of genital infections and vaginal flora in nonpregnant and pregnant women, Consequences of genital infections and commensal vaginal flora to mother, Fetus and neonate during pregnancy, Etiology and prevention of infectious pregnancy complications.

Macaulay A.C. Onuigbo is an Associate Professor in Medicine - College of Medicine, Mayo Clinic
Regional Director - Mayo Health System Practice-Based Research Network,
Vice Chairman - Department of Nephrology, Luther Midelfort
Mayo Health System MacMillan Management Scholar Award -  Mayo Clinic
Fellow of the American Society of Nephrology (FASN)
Fellow of the West African College of Physicians (FWACP)
Editorial board member/reviewer of reputable journals, including Editorial Board member, Quarterly Journal of Medicine.
Over 80 publications in print
Two book chapters

NEW DISCOVERIES:
Described two new syndromes – late-onset renal failure from angiotensin blockade (LORFFAB) and syndrome of rapid-onset end-stage renal disease (SORO-ESRD)
 

Hepatitis B in Hemodialysis patients
RAAS blockade and kidney function
The natural history of CKD
Diabetic nephropathy
Hypertension
Viral infections in Transplantation
Acute renal failure
Reno-prevention strategies
Intra-dialytic hypotension
End-stage renal disease
Statistics in medical publications
Typhoid fever, malaria and FUO
Anemia in CKD.

Avni Y. Joshi is a Senior Associate Consultant in Division of Pediatric Allergy, Immunology and Pulmonology in Department of Pediatric and Adolescent Medicine-Mayo Clinic. He interested in improving patient care through education and research. Currently he is enrolled in the Clinical Research training program and plan to complete the Masters in Clinical research. He is serving as an editorial board member for 3 reputed journals.

Primary Immunodeficiency Disorders, Vaccines, Secondary immunodeficiency disorders, Bonemarrow transplantation for immunodeficiency disorders.

Epidemiology.

Robert S. Duszak Staff Optometrist in the Eye Institute of the Pennsylvania College of Optometry, Philadelphia. He is serving as member in several communities. He is author of more than 15 research articles published in reputed journals.

Retinopathy.

Dr. Dechu C. Tang is a Scientific Founder, Vice President of Research, and Chief Technical Officer at Vaxin Inc. He obtained his PhD in Microbiology from Indiana University in 1989. He carried out his postdoctoral work at Baylor College of Medicine, Duke University, and the University of Texas Southwestern Medical Center. He joined the faculty at the University of Alabama at Birmingham in 1994 and subsequently founded Vaxin Inc. in 1997. Dr. Tang was a pioneer during the development of DNA vaccines, noninvasive epicutaneous vaccines, adenovirusvectored influenza and anthrax vaccines. He is serving as an editorial member of Journal of Vaccines Vaccination and Expert Review of Vaccines. He received the Wallace H. Coulter Award for innovation and entrepreneurship in 2000; Vaxin Inc. was selected as a Tech Museum Awards Laureate in 2007.

His special interests include treatment of the common cold, prophylaxis and treatment of infections in transplant recipients, and hepatitis C virus epidemiology.

Howard L. Kaufman is the Director of the Rush University Cancer Center. He also serves as an Associate Dean of the Rush University Medical Center and is Professor of Surgery, Internal Medicine-Medical Oncology, and Immunology & Microbiology at Rush University Medical College. Dr. Kaufman completed medical school at Loyola University in Chicago, surgical residency at Boston University and fellowship training in Tumor Immunology and Surgical Oncology at the National Cancer Institute in Bethesda, Maryland. He serves on several editorial boards and has published over 200 manuscripts, books, book chapters, review articles and abstracts. He is as a consultant to the NCI and several pharmaceutical and biotechnology companies and was recently appointed to the Board of Directors of the iSBTc. He has conducted over 50 clinical trials, including Phase I, II and III investigator-initiated, industry-sponsored, NIH-sponsored, cooperative group and multi-institutional studies related to the role of immunotherapy and surgical resection as treatment options for patients with melanoma and other cancers.

Cancer immunotherapy
Melanoma vaccines.

Alan Escher is Associate Director of the Center for Transplant Immunology Research at the Loma Linda University School of Medicine and Medical Center in Loma Linda, California, Associate Professor, Department of Basic Sciences, School of Medicine, Loma Linda University, He has received a PhD in Microbiology in 1992 from Cornell University, Ithaca, New York. He has completed his BSc in Biology in 1985 at the University of Connecticut, Storrs, Connecticut. He is serving on the Editorial board of the American Journal of Biochemistry and Biotechnology and the American Journal of Immunology.

DNA vaccines Immune tolerance Autoimmune diseases Allotransplantation Biotechnology Immunology.

Sherif Beniameen Mossad, MD, has been a member of Staff in the Department of Infectious Diseases at Cleveland Clinic since 2000. He served as an Associate Staff member from 1998 to 2000 and as a Clinical Associate from 1996 to 1998. Dr. Mossad is also Associate Professor of Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and Clinical Assistant Professor of Medicine in the College of Medicine at Pennsylvania State University. Dr. Mossad obtained his medical degree in 1988 from the University of London. In 1988-1989, he served as House Officer at Cairo University Hospital, Egypt. He completed a rotating internship in child psychiatry at the Egypt Child Psychiatry Clinic, and performed community service for the Ministry of Health, Cairo, from 1989-1990. He was a Resident in internal medicine at Cairo University Hospital from 1989-1990. Dr. Mossad also completed internal medicine residency from 1990 to 1993, and infectious disease fellowship, from 1993 to 1996, at Cleveland Clinic, Cleveland, Ohio. His special interests include treatment of the common cold, prophylaxis and treatment of infections in transplant recipients, and hepatitis C virus epidemiology.

His special interests include treatment of the common cold, prophylaxis and treatment of infections in transplant recipients, and hepatitis C virus epidemiology.

Michael R. Shurin is an Associate Professor of Pathology and Immunology. He is serving as Associate Director of Clinical Immunopathology in University of Pittsbrgh Medical Center, USA.

Tumor-induced immunomodulation Molecular mechanisms of the regulation of dendropoiesis in cancer Immunobiology of dendritic cells in cancer Psychoneuroendocrine factors of immunosuppression in cancer Dendritic cell-based immunotherapy for cancer - new approaches and modalities

Hematology and Oncology

Anthony G. Brickner is an Assistant Professor of Medicine and Immunology at the University of Pittsburgh Cancer Institute. He obtained his PhD in Developmental Biology from the University of Cincinnati school of Medicine in 1998, and carried out his postdoctoral work at the University of Virginia in cellular immunology.

1. Identification and characterization of human minor histocompatibility antigens
2. Minor histocompatibility antigen-based immunotherapy for hematologic malignancies after hematopoietic stem cell transplantation
3. Molecular and cellular biology of gene products overexpressed in B-lymphoid malignancies
4. Proteomics applied to B-lymphoid malignancies

In college, Dr. Reed majored in Microbiology, obtaining both a Bachelor of Science degree in 1987 and a Master of Science degree in 1990 from Oklahoma State University. In 1995 he graduated from the University of Texas Southwestern Medical Center at Dallas with a Ph.D. in Immunology. From 1995 to 1999 Dr. Reed worked in the laboratory of Dr. Leo Lefrancois and Dr. Lynn Puddington at the University of Connecticut Health Center in Farmington, CT. Under their tutelage, Dr. Reed gained expertise in studying T lymphocyte responses to antigens entering through the intestinal mucosa and respiratory tissues. In 1999, Dr. Reed moved to the U.S. Army Medical Research Institute of Infectious Diseases where he served as a Microbiologist developing animal models and testing vaccines against a number of pathogens, including anthrax, plague, Venezuelan equine encephalitisvirus , Eastern equine encephalitis virus, as well as the Ebola and Marburg viruses. Along with his collaborators, he was awarded the 2003 Army Research Development Award for the successful design and testing of new vaccines for Venezuelan equine encephalitis viruses in nonhuman primates, work that was instrumental in initiating phase I clinical trials of these vaccines. In 2008 Dr. Reed became the manager of the Aerobiology core at the University of Pittsburgh’s Regional Biocontainment Laboratory. In that role, Dr. Reed develops animal models for respiratory and biodefense pathogens and tests medical countermeasures designed to protect against those pathogens.

His current research interests include developing animal models for aerosol exposure to Rift Valley Fever virus and testing and developing safe & protective live vaccines against pneumonic tularemia in rabbit and nonhuman primates.

Philippe Krebs is a Research Associate at the Scripps Research Institute USA. He completed undergraduation at University of Fribourg Institute of biochemistry. Philippe Krebs is author of more than 30 research articles.

Infections and autoimmunity, Molecular characterization of virus-induced autoantibody responses.

The research in my lab is focused on CD1d-mediated NKT cell activation and the assays used to monitor this interaction are typically ELISA and flow cytometry. A variety of molecular techiques are also used to measure downstream signaling events and to modulate the function of proteins of interest.

Marc A. Jeuland is an Assistant Professor in the Sanford School of Public Policy and the Duke Global Health Institute at Duke University. He received a PhD in Environmental Sciences and Engineering from the School of Public Health at the University of North Carolina at Chapel Hill 2009, a Masters of Science in Environmental Engineering from the University of North Carolina at Chapel Hill 2006, and a B.S. in Engineering from Swarthmore College, Swarthmore, PA 2001. He has published in leading journals such as the Journal of Development Economics, the World Bank Economic Review, Value in Health, Vaccine, Water Resources Research and the Journal of Policy Analysis and Management. He has served as a reviewer for a number of journals publishing articles related to environmental and health economics and policy.

Water and sanitation, and environmental health in developing countries Valuation using stated and revealed preference techniques Economics of vaccines and preventative health interventions Cost-benefit analysis Cost-effectiveness analysis

Lewellys F. Barker, MD, MPH, is currently Senior Medical Advisor, overseeing Regulatory Affairs and Quality Assurance, and Director of Policy at the Aeras Global TB Vaccine Foundation in Rockville, Maryland. He is a graduate of Princeton University and Johns Hopkins University School of Medicine and School of Public Health. His postgraduate training was in Internal Medicine at the Johns Hopkins Hospital and New York University/Bellevue Hospital. He served in the US Public Health Service as a medical research bench and clinical investigator and senior manager with the NIH Division of Biologics Standards and the US Food and Drug Administration Bureau of Biologics, and at the Division of AIDS of the US National Institutes of Health/National Institute of Allergy and Infectious Diseases, with responsibilities for product development, regulation, and application of vaccines, drugs and diagnostics. He also worked as a Senior Vice President at the American Red Cross National Headquarters with responsibility for the Red Cross.

He has published extensively on preclinical and clinical research on a variety of biomedical products, disease detection, epidemiology, risk assessment, treatment and prevention of infectious diseases.

Dr. Yisong Wan is a faculty at the Department of Microbiology and Immunology at the University of North Carolina at Chapel Hill. He is also affiliated with the Lineberger Comprehensive Cancer Center. Dr. Wan received his Ph.D. in Molecular Genetics and Biochemistry at the University of Colorado and did his postdoctoral training at Yale University.

We are interested in T cell biology and immune suppression. Our research focus is on studying the regulation and function of Treg cells and TGF-beta signaling in controlling T cell mediated immunity, auto-immunity and inflammation.

Ioanna Skountzou Assistant Professor Ioanna Skountzou majored in Biology 1980 and received her M.Sc. in Biochemistry from the University of Wisconsin, Madison1983. She received her Medical degree from the University of Patrai 1990 and her PhD in Immunology from the Aristotle University of Thessaloniki, Greece 1993. She is Board certified in Pathology and Laboratory Medicine. She is currently working at Emory University Medical School, Department of Microbiology and Immunology and she is an Investigator of the Influenza Pathogenesis and Immunology Research Center IPIRC, Emory UniversityUGA. She has authored several research articles and chapter books on HIV and influenza vaccines.

Pathogenesis of influenza and parainfluenza viruses and vaccine development, virus induced host immune mechanisms, transcutaneous immunization, innate immunity.

Dr. Alwyn Rapose now enjoys practicing medicine in Massachusetts. He completed his Internal Medicine residency at St. Vincent Hospital in Worcester and liked the experience so much that he stayed on board for another year as Chief Resident. He then completed his Infectious Disease fellowship at the University of Texas Medical Branch in Galveston, Texas.
Dr. Rapose felt that Fallon Clinic was a good fit and a great place to start his career as an Infectious Disease specialist. “I had worked with Fallon Clinic physicians when I was a resident. That is the reason I came back to this area – I knew I would be working with people that I really respect and could learn from,” he explains.
Dr. Rapose originally studied engineering in college, but began to feel strongly that becoming a doctor is what he was destined for. “God wanted me to become a doctor. I think He put that desire in my heart, and then helped me to make that choice. It’s been a great experience.”
Infectious Disease is a specialty that Dr. Rapose is familiar with, it’s the closest field to what he had been trained for in India. “Infectious Disease is a subspecialty of medicine, but you feel like an internist at the same time. In this field you have to think like a specialist and an internist. You have to be a good, allaround physician. That’s why I enjoy it so much.”
Dr. Rapose tries to reassure his patients and give them faith that they will recover. He believes that it’s important to treat not only peoples’ illnesses, but their mental and spiritual health as well. “I am willing to share my Raposeal experiences if it helps people achieve a positive attitude. When they are suffering, I think a positive attitude helps them recover faster.”
One of the biggest challenges that Infectious Disease physicians face today are the “superbacteria” that are highly resistant to many of the medications available. “Fortunately, we are developing new antibiotics and new ways of treating these patients. These organisms are difficult to treat, but we are taking up the challenge and beating them.”
In his spare time, Dr. Rapose loves to get out and meet people and spend time with family and friends. He also plays the guitar and is part of his church’s music choir. Dr. Rapose enjoys traveling and has visited many places during his time in the United States, including Puerto Rico, Texas and California.

HIV infection, as well as severe pneumonia cases and meningitis. He often deals with illnesses related to extended hospital stays, organ transplants or infections following surgery.

Alicia Solorzano completed her graduation in 2001 at the Instituto de Microbiología Bioquimica IMB at Salamanca University, Spain. Present I am a Research Assistant Professor at Department of Veterinary Medicine at University of Maryland. She is one of the members in ASV, ISIRV, CRWAD.

My current interest is the development of live-attenuated influenza vaccines against influenza. I have constructed live-attenuated vaccine strains for swine influenza and I am evaluating their potential in efficacy and protection. In addition I am also trying to understand the molecular mechanisms that make these viruses attenuated.

Microbiologist at Centers for Disease Control and Prevention 2003 until now He finished his postdoc training at Department of Veterinary Pathology at University of Georgia 1999 to 2003 Former general secretary of the Committee of Chinese Veterinary Microbiology Society 19961998 Expert panel reviewer for licensing veterinary biologicals at China Institute for Veterinary drugs and Biologicals 1995 to 1998. Received his Ph. D and D.V.M from School of Veterinary Medicine, Nanjing Agricultural University 19851995 Reviewed papers for journals: Vaccine, Virus Res, Antiviral Res, Arch Virol, Microbiol Immunol. Emerg Infect Dis, and Veterinary Microbiol. Published 2 books, filed two patents, and published more than 20 research papers.

Rabies vaccines and pathology Vaccine R & D Vaccinology and immunology Vaccine licensing and related regulations RNA virus research, protein/protein interactions, protein/RNA interactions RNA virus evolution Neuronal virology and neuronal degenerative diseases after virus infections.

Dr. Vardeny joined the School of Pharmacy at the University of Wisconsin as Assistant Professor CHS in the Pharmacy Practice Division in 2004. She received her Doctor of Pharmacy Degree at the University of Utah in 2000. Thereafter, she completed a Specialty Residency in Ambulatory Care at the University of Utah Hospitals and Clinics, focusing on Internal and Family Medicine, followed by a Fellowship in Experimental Cardiovascular Pharmacotherapy.

Dr. Vardeny is interested in heart failure research, and focuses on delineating contributions of beta adrenergic pathways on metabolic abnormal-ities and immune function in patients with heart failure. She is currently working on a number of projects: one study investigates the effects of beta adrenergic blockers and polymorphisms in the beta-2 adrenergic receptor on glucose handling in patients with heart failure, and another examines beta adrenergic effects on immune responses to influenza vaccine heart failure patients.

Sang-Moo Kang is an Assistant professor in the Department of Microbiology and Immunology in School of Medicine at Emory University, Atlanta, USA.

Microbiology and Immunology

Mark R. Schleiss, M.D. is a Professor of Pediatrics in the division of Infectious Diseases. Dr. Schleiss is the Director, Division of Infectious Diseases, Associate Head for Reseach, Department of Pediatrics and the American Legion Chair of Pediatrics. Dr. Schleiss received his M.D. degree from the Oregon Health and Sciences University, Portland, Oregon. He completed his residency at Doernbecher Children Hospital, Oregon Health and Sciences University, Portland, Oregon and his Pediatric Infectious Diseases fellowship at Children\s Hospital Medical Center, University of Washington, Seattle, Washington and a fellowship in Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Infectious Diseases - Pediatric

K. Raviprakash is a Senior Scientist at Naval Medical Research Center, USA.

Vaccination

Zhao Lu is a Research Associate in the Department of Population Medicine and Diagnostic Sciences in College of Veterinary Medicine at Cornell University, USA.

Design and analysis of vaccines and vaccination using mathematical and statistical approaches

Justin is Head of Process Development, and has over 15 years of experience in microbiology. He has developed methods for the GMP production of liveattenuated and KBMA Listeria vaccines. Dr. Skoble earned his Ph.D. at University of California, Berkeley in the laboratory of Dr. Daniel Portnoy investigating the interactions between Listeria monocytogenes and host cells. Dr. Skoble performed postdoctoral work at UCSF in the Laboratory of Dr. Jeff Cox studying Mycobacterium tuberculosis pathogenesis.

GMP production of live-attenuated and KBMA Listeria vaccines

Aldar S. Bourinbaiar is CEO of Immunitor USA Inc., manufacturer and developer of oral vaccines. He received M.Sc. in Zoology/BioStatistics from National University of Mongolia, UlanBator, Mongolia. Trained in Computer Programming/Statistics, Jan Comenius University, Bratislava, Czechoslovakia, M.Sc. D.E.A. in Population Genetics Epidemiological Anthropology, University of Paris VII, Ph.D. 3eme cycle in Cancer Immunogenetics Cytogenetics, University of Paris VII, M.D./Ph.D. D.E.R.B.H. in Experimental Oncology, Transplantation and Cancer Immunology, KremlinBicetre Medical School, University of Paris XI, M.A. in Mongolian History and Civilization, Sorbonne Nouvelle, University of Paris III, Paris, France, B.A. in Russian Literature and Language, Sorbonne Nouvelle, University of Paris III, Paris, France. Fluent in Mongolian, Russian, French and English. Basic knowledge of Japanese, Slovak, and Thai. Fellow of Claude Bernard Association, Paris, France. Fellowship award from NATO Institute for Advanced Studies. Award of excellence in research by Hayashibara Biochemical Co., Japan. Published over 130 publications and 5 books. Six awarded US patents on antiviral and anticancer drugs. He is serving on editorial board of three peer reviewed journals. Elected as Thailand's regional representative by International Organization on Biotechnology and Bioengineering, Stockholm, Sweden. Expert member of the Society of Industry Leaders, a division of Standard Poor's, New York. NIH grant reviewer on AIDS related projects for 20052006 cycle. Listed in International Who is Who Professionals, Marquis Who's Who, Marquis Who's Who in Asia, Who is Who Historical Society, Cambridge's 2000 Outstanding Intellectuals of 21st Century.

Immunophenotyping and cytohistochemistry. Flow cytometry and cell sorting. Fluorescence and electron microscopy. ELISA and radioimmunoprecipitation (RIPA) assays. Monoclonal antibody preparation and biotin labeling. Antibody-antigen interaction. Vaccine development. Immunoglobulin isotyping. CTL and MLR assays. Apoptosis. CTL cloning and limiting dilution assays. Cell adhesion assays. Characterization and culture of primary and established tumor cell lines. Inflammatory mediators. Leukocyte enzymes, cytokines, interferons, growth factors, neurotransmitters, and hormone assays. Reproductive physiology and endocrinology. Semen and sperm analysis. Signal transduction. Transmembrane transport. Endocytosis and phagocytosis. Preparation and extraction of DNA, RNA, and mRNA. Hirt extraction. Recombinant DNA methodology. Cloning and gene expression. Rabbit reticulocyte transcription/translation assay. CAT assay. Quantitative PCR and RT-PCR. Southern and Northern blot and gel analysis. Chromosome preparation and karyotyping. Isotopic and non-isotopic in situ hybridization and detection. Agarose and PAGE electrophoresis and Western blot. Protein purification, chromatography, chemistry and crystallization. Receptor binding and ligand radiolabeling. Functional and quantitative protease assays and identification. Topoisomerase assay. General microbiology and bacteriology. Methods for growth, isolation, purification, detection and quantitation of HIV, HTLV, and herpesviruses. Reverse transcriptase and integrase assays. In vitro assays for antiviral drugs and vaccines. Computer and statistical analysis of data related to clinical trials. Clinical trials organization. Grant writing and soliciting from public and private foundations. Extensive database search experience for gene and amino acid sequences.

Investigator initiated Phase I/II clinical trial of azacitidine in combination with lenalidomide for elderly, previously untreated AML patients (PI), Characterization of the structure, function and prognostic value of the TET2 gene in myeloid malignancies.

Eunha Shim is an Associate Research Scientist, School of Public Health, Yale University. She has received a Ph.D. in Mathematics and Statistics from Arizona State University, AZ, in 20042007. She has completed her M.S. in Mathematics in the University of British Columbia, Vancouver, BC, Canada 2004. She has completed her B.S. in Mathematics in the University of British Columbia, Vancouver, BC, Canada 2002. She is serving as a reviewer of 12 journals Science, Proceedings of the National Academy of Sciences, Vaccine, Journal of Theoretical Biology, Mathematical Biosciences, Journal of Biological Dynamics, Mathematical Biosciences and Engineering, BMC Public Health, International Journal of Infectious diseases, PLoS Neglected Tropical Diseases, PLoS ONE, and Journal of Nonlinear Analysis B: Real World Applications. She has coauthored ten publications.

Computational epidemiology Game theoretical application to epidemiological modeling Evolution of infectious diseases Mathematical biology

Dr. Simon Graham received his PhD in Immunology from the University of Liverpool during the period of 1994 1998. Currently, he is working as Head of the Host Pathogen Interaction Research Unit in the Virology Department of the Veterinary laboratories Agency, UK. He has authored 27 research articles/books. He is a member of British Society for Immunology.

Cell mediated immunity against intracellular pathogens of veterinary species and its application to vaccine development.

Hung Fu Tseng had completed his Bachelor Science in China Medical College, Tapei, his MPH in University of California, Los Angeles and his PhD in University of California, Los Angeles.

• Vaccine and drug safety and effectiveness
• Cancer
• Genetic epidemiology
• Infectious diseases

Claudia Gravekamp, PhD, is an Associate Professor in the Department of Microbiology and Immunology of Albert Einstein College of Medicine in New York. She received her PhD in 1988 in the field of Tumor Immunology at the Erasmus University in Leiden, The Netherlands. From 1987-1993, she served as head of the Laboratory for Leptosirosis at the Royal Tropical Institute in Amsterdam, the Netherlands. In 1993, she started as a Research Fellow in Medicine of Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, and became an Instructor in Medicine in 1995 until 1998. From 1998 to 2006, she was an Associate member in the Department of Drugs Development of the Cancer Therapy and Research Center as well as an Assistant Professor at the University of Texas Health Science Center, both in San Antonio, TX. From 2006-2008, she was a Scientist at the California Pacific Medical Center Research Institute in San Francisco, CA. With her research team she has developed novel DNA- and Listeria-based cancer vaccines and studied their efficacy in preclinical models at young and old age. She has published 46 scientific articles. She is serving as a member of the Editorial Board Mechanisms of Ageing and Development, and is Ad-hoc reviewer for various scientific journals (Cancer Immunology Immunotherapy, Clinical Cancer Research, Cellular Immunology, Transplantation Infectious Disease, Biogerontology).

CD8+ T cell biology, vaccination, ENU mutagenesis, cross-talk innate / adaptive immunity, Toll-like receptor signaling, inflammation.

Dr. Johnstone obtained her medical degree from Dalhousie University in Halifax, Nova Scotia. She then moved to Edmonton, Alberta where she completed her Internal Medicine and Infectious Disease training at the University of Alberta. Following her residency she completed a clinical research fellowship in Edmonton. She moved to Hamilton, Ontario in July 2008 and is currently practicing Infectious Diseases at McMaster University, where she is an Assistant Professor. She is also completing her PhD in epidemiology at McMaster University.

Respiratory infections Immunosenescence Vaccine preventable infections in the elderly Epidemiology

Dr. Isabel Gimeno received the degree of Doctor in Veterinary Medicine in 1995 by the Universidad Complutense de Madrid and her PhD in 1999 by the same University. In 2002 she became diplomate of the American College of Poultry Veterinarians. Currently, she is working as assistant professor at the College of Veterinary Medicine, North Carolina State University. She is member of several professionals associations and she is serving as an editorial member of the journals Avian Diseases and Journal of Vaccine and Vaccination. In addition, she serves as ad hoc reviewer for Avian Pathology, Vaccine, Veterinary research, Expert Review of Vaccines, and Veterinary Pathology. She has authored 30 research articles, 2 book chapters and coauthor one book and two slides study sets. She has been key note speaker in 25 international meetings. She has received several academic and research awards.

• Avian tumor viruses
• Emerging poultry infectious diseases
• Poultry immunology
• Poultry pathology

Adult hematopoietic stem/bone marrow transplantation (HSCT) involves the transfer of donor cells to patients/recipients suffering from leukemia, lymphoma or other blood/bone marrow cancers. Dr. Sarantopoulos primary laboratory interest is study of the significant immune pathology that develops in patients who have undergone HSCT. While HSCT offers the possibility of cure for many patients with hematologic diseases, the full potential of HSCT has not been realized because of transplant-related complications. Chronic graft versus host disease (GVHD) has become the most significant post-HSCT cause of morbidity and mortality. Chronic GVHD has an adverse impact on survival that has not improved significantly over the last 30 years. The only standard therapy for chronic GVHD is high-dose steroids. Targeted therapy for chronic GVHD has been difficult to develop due to limited understanding of immunopathologic mechanisms in human cGVHD. Responses to rituximab suggest that B cells play a role in cGVHD, but the mechanisms that promote and sustain B cell involvement have not been elucidated. If we can better understand the pathophysiology of chronic GVHD we can develop targeted therapeutic agents specific for BAFF pathways and activated B cells that may lead to decreased morbidity and mortality in our patients.

Dr. Sarantopoulos primary laboratory interest is study of the significant immune pathology that develops in patients who have undergone HSCT.

Zhengwu Lu received MD from Anhui Medical University China in 1988, and PhD in Pharmacology from Beijing University Health Sciences Center in 1994. He received a program certificate in Computer Programming and Database Development from the Praxis Training Institute, Ottawa, Ontario, Canada in 1998. He published about 30 scientific papers in peerreviewed biomedical journals and conference proceedings. His major contributions have been in the research and development of animal models to study psychneuroendocrineimmunitydisease susceptibility and interventions involving immunopharmacology, and technology applications in clinical research. In recent years, he has performed clinical applications design and development in various biomedically related industries. He has participated in clinical study protocol preparation/review, developed clinical applications, led clinical/lab systems development/validation projects, and designed clinical trial case report forms using electronic data capturing technologies. He is currently a Sr. IEEE member and working as clinical research consultant in the biopharmaceutical clinical trial industry. He acts as an editor or reviewer for a number of peerreviewed biomedically related international journals. His current research interest lies in systems biomedicine, clinical research, eclinical systems engineering, technologysupported clinical trial optimization, and clinical informatics.

His current research interest lies in systems biomedicine, clinical research, e-clinical systems engineering, technology-supported clinical trial optimization, and clinical informatics.

Nicholas Johnson is Deputy Head of the Rabies and Wildlife Zoonoses Group at the Veterinary Laboratories Agency. He has received a PhD in Molecular Biology Microbiology, University of Southampton. He has received a BSc in Microbiology, University of Newcastle Upon Tyne. He is a member of the Society for General Microbiology and the Veterinary Research Club, UK. He has published extensively on zoonotic viruses with over 70 peerreviewed publications, particularly on rabies virus. He is an occasional reviewer for a range of journals including Vaccine, Journal of Clinical Microbiology, Virology, Journal of Global Infectious Disease and Epidemiology.

Rabies virus Vaccinology, Epidemiology and Pathogenesis Non-rabies lyssaviruses, particularly European bat lyssavirus Vector-borne Viruses including West Nile virus Host innate Immune Responses to Infection Arthropod Vector Competence for Viral Replication New Virus Discovery

Ramin M. Hakami is an Assistant Professor of Molecular and Microbiology at the National Center for Biodefense and Infectious Diseases at George Mason University. He has received a PhD in Biochemistry 1995 from the Massachusetts Institute of Technology, Cambridge, MA, under the mentorship of the Noble Laureate Professor Gobind Khorana. He has completed his B.S. in Chemistry at Stony Brook University, New York, NY 1989. He has coauthored 22 peerreviewed publications to date.

Immunology and Infectious Diseases Host-Pathogen Interactions Proteomic and Phosphoproteomic Profiling Studies Vaccines and Therapeutics

Dr FT Fraunfelder’s formal medical education was at Oregon Health Science University the University of Chicago School of Medicine Johns Hopkins School of Medicine and Moorefield’s Eye Hospital at the University of London.  He is author or coauthor of 14 medical textbooks on the eye and over 200 peer review scientific articles. One of these books a series of five was awarded as one of the outstanding medical ocular textbooks of the 20th century In 2008 he coauthored “Retirement Rx” Penguin Group. This is in hard back in English French big print and kindle. The paper back edition “Retire Right” was published in 2009. Dr Fraunfelder is the founder of the Casey Eye Institute at Oregon Health Science University and is director Emeritus.

He specializes clinically in ocular oncology and his research focuses on druginduced ocular side effects.

Dr. Mohamed Lotfy Elsaie is a dermatologist who serves as a voluntary instructor of dermatology and cutaneous surgery at university of miami miller. Moreover he is a lecturer of Dermatology at the national research centre in cairo, Egyptology. He sustained a high level of residency training and intenrship in the USA in Memorial Sloan Kettering Cancer Research Centre in New York as well as Thomas Jefferson school of medicine in Philadelphia as a visiting resident of dermatology. A member of 10 International societies of dermatology. He is an Associte editor of the journal of drugs in dermatology and an Editorial consultant of Lasers in Medical science Journal. Being a Researcher and lecturer in the field of dermatology, Dr. Elsaie has served in much of clinical research and participated with several studies, talks and abstracts in conferences, national wise and internationally. Expertise: * Cutaneous Laser Surgery *Laser Skin Resurfacing * Laser treatment of vascular lesions * Laser treatment of pigmented lesions *Laser assisted hair removal * Botox and Articoll collagen injections for treatment of facial wrinkles and scars * Superficial and medium depth chemical peeling * Minor dermatological surgical procedures. Dr. Elsaie is an author of more than 40 published researches and an author of more than 15 book chapters in the fild of Dermatology and cutaneous surgery.

General dermatology cosmetic dermatology dermatologic surgery stem cell and skin disease.

Joseph J. Kishel is a Clinical Assistant Professor of Pharmacy Practice at University of the Sciences in Philadelphia.

Pharmacology & Clinical Pharmacy Specialist in Infectious Diseases

Dr. Michael Landrum graduated Magna Cum Laude in 1995 from Truman State University with a bachelor of science degree in chemistry and then attended the University of Missouri School of Medicine, graduating Magna Cum Laude in 1999. He subsequently moved to San Antonio, TX for his internship and residency in internal medicine at Wilford Hall Medical Center, part of the San Antonio Uniformed Services Health Education Consortium. After the completion of his residency in 2002, he served for one year as Chief of Residents. Following graduation from the San Antonio Health Education Consortium fellowship in infectious diseases in 2005, he was assigned to Wilford Hall Medical Center as a staff in infectious diseases, where he was deployed in support of Operation Iraqi Freedom in 2006. In 2007 he took a position with the Infectious Disease Clinical Research Program of the Uniformed Services University of the Health Sciences. He currently holds academic appointments with the Uniformed Services University of the Health Sciences as an assistant professor of medicine, preventive medicine and biometrics and with the University of Texas Health Science Center in San Antonio as a clinical assistant professor of medicine. He serves as reviewer for several infectious disease journals including Clinical Infectious Diseases, Vaccine, and AIDS. His current research interests include clinical vaccine development, and the use of vaccinations in HIVinfected patients.

His current research interests include clinical vaccine development, and the use of vaccinations in HIV-infected patients.

I am a Research Fellow funded by the Scottish Governments Centre of Excellence in Epidemiology, Population Health and Disease Control EPIC. I received Doctorate in Veterinary Medicine from Kharkov State Zooveterinary Academy, Kharkov, Ukraine and PhD in Veterinary Medical Science with minor in Statistics from College of Veterinary Medicine and Department of Mathematics and Statistics, Mississippi State University, USA. My research work started in Institute for Experimental and Clinical Veterinary Medicine, Ukrainian Academy of Agrarian Sciences, where I worked for several years on different aspects of diagnostics, vaccinology and control of Classical Swine Fever and Porcine Reproductive and Respiratory Syndrome. I participated in outbreak investigation of Infectious Laryngotracheitis in commercial broilers in the state of Mississippi in 20022003. I then worked at CVM, MSU during 20032007 within the project Risk Factor Analysis of Salmonella and Campylobacter status of Broiler Flocks funded by USA National Research Initiative Epidemiological Approaches to Food Safety, CSREES , USDA. While in CVM, MSU, I participated in Mississippi Poultry Health Roundtable, academiaindustry interface veterinary extension programme, and assisted in teaching veterinary epidemiology and preventive veterinary medicine to veterinary professionals and graduate students. At the same time I carried out my PhD research on risk factor analysis of preharvest Salmonella status of broiler flocks in southern United States. I was elected to membership in The Society of Phi Zeta, the USA honour society of veterinary medicine, and was a student member of CRAWD and AAVLD. I am a charter member of EvidenceBased Veterinary Medicine Association .

My research concerns epidemiology and control of infectious diseases of animals.

Veterinary Pathology

Graduate in Medicine Specialist in Clinical Toxicology Specialist in Clinical Nephrology Medical Assistant at Unit of Cinical Pharmacology of Faculty of Medicine, Federico II University of Naples, from 1982 to 1997 Assistant Professor at Unit of Clinical Pharmacology of Faculty of Medicine, “Federico II University” of Naples, from 1998 till today Temporary lecturer of Pharmacodiagnostics at “School of Biomedical Laboratory Technician” of Faculty of Medicine, Federico II University Temporary lecturer of Pharmacology at School of “Medical Radiology Technician” of Faculty of Medicine, Federico II University Temporary lecturer of Pharmacology at “Nursing School” of Faculty of Medicine, Federico II University Temporary lecturer of Pharmacology at “Techniques of Cardiovascular Physiopathology and Cardiovascular Perfusion” of Faculty of Medicine, Federico II University Collaborator with teaching activity and member of Committee of exams of Pharmacology at “School of Medicine” and “School of Odontology” of Faculty of Medicine, Federico II University.

"My research interests have been always addressed to the field of clinical pharmacology and toxicology. In fact, I carry out clinical studies with regard to therapeutic monitoring, pharmacokinetics of drugs, in particular immunosuppressive drugs,as cyclosporine, tacrolimus, sirolimus, mycophenolic acid and everolimus.Recently, my scientific activity is also devoted to study the pathophysiologic mechanisms of liver diseases, particularly drug-induced.

Dr Barry Walker is P.I. of the Immunology and Cellular Immunity section within the Biotherapeutics group at NIBSC. The main area of interest is the study of cellular immune responses involved in protective immunity to pathogens and in particular, pathogen specific immunity elicited through vaccination with a focus on M tuberculosis, the causative organism of tuberculosis. Dr Walker established the first murine aerosol challenge facility for tuberculosis in the UK undertake evaluations of new vaccine approaches. Dr Walker provides expert guidance and advice on preclinicalclinical development of TB vaccines and is also involved on work targeted at harmonisation and standardisation of the clinical immunological assays used in TB vaccine trials. Parallel work preparing and characterising standards and reference materials for these clinical trials is also a major interest. Activities EMEA Expert advisory Group WHO advisory group on BCG HPA/WHO observer DCVRN tuberculosis vaccines HPA/WHO Observer AVAREF tuberculosis vaccines HPA/WHO advisor on TB vaccine clinical trial end points and Immune Assay Harmonisation Consultant to PATH Member of TBVI

Tuberculosis and the immunology of vaccines against poverty related diseases, including HIV and Malaria.

Dr. Anupa Patel received her MD in 2004 and completed redicency and chief residency in NY. Currently, she is working as a senior endocrinology fellow at Scott White Memorial Hospital in association with Texas AM Health Sciences Center. She has authored 1 peerreviewed articles thus far in her early career. She is a member of Endocrine Society, AACE, AMA, and ACP.

Diabetes mellitus, Thyroid disorders

Matthias Imohl, Institute of Medical Microbiology, National Reference Centre for Streptococci, University Hospital RWTH Aachen, Germany. He has obtained a qualification in Transfusion Medicine in 2005. He has completed a specialisation in Laboratory Medicine in 2004. He has received his MD in Bochum, Germany 1999.

Streptococci Pneumococcal vaccination.

Claudius Malerczyk, MD, is currently Head of Medical Affairs region Middle East and Africa at Novartis Vaccines and Diagnostics, Marburg, Germany. School of Medicine, Frankfurt University, Germany He has received an MD and Dr. med. from Frankfurt University. He completed his ‘Arzt im Praktikum’ at Frankfurt University hospital and Center for Cardiovascular Pharmacology, Mainz, Germany He held a postdoctoral position at Lombardi Cancer Center, Georgetown Univ., Washington DC., USA And a second postdoctoral position at Philipps University, Marburg Germany Several positions in pharmaceutical industry in Clinical Research and Medical Affairs He is serving as a reviewer of 6 journals Number of publications: 26 reviewer for: Vaccine Human Vaccines Journal of Travel Medicine Transactions of the Royal Society of Tropical Medicine Hygiene BMJ Bulletin of the World Health Organization

Vaccinology Immunology Vaccine development Clinical Research Zoonoses Rabies Influenza Meningococcal Disease Pediatric combination vaccines Intradermal vaccination

Internal Medicine

Ramzi A. Alsallaq is a Postdoctoral Fellow in Theoretical Epidemiology at the Department of Global Health and Medicine, University of Washington, Seattle, WA. Postdoctoral Research Fellow, Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, OH. Postdoctoral Fellow, Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA. Postdoctoral Associate, Institute of Molecular Biophysics, Florida State University, Tallahassee, FL. He has received a PhD in Theoretical Physics with specialization in Biophysics from Florida State University, Tallahassee, FL. He has completed his BSc in Physics from the University of Jordan, Amman, Jordan.

Quantitative methods in infectious diseases including mathematical modeling and related standard epidemiological statistics. Natural history of sexually transmitted diseases and related system biology processes. Theoretical simulation of dynamical biological processes.

Mattia BONSIGNORI is a Medical Instructor in the Department of Medicine at Duke University Medical Center, a Faculty member of the Duke Human Vaccine Institute and a member of the Duke Center for HIV/AIDS Research CFAR. He currently works at the Duke Human Vaccine Institute within the framework of the Center for HIV/AIDS Vaccine Immunology CHAVI. He was previously a postdoctoral associate in the Department of Immunology at St. Jude Children’s Research Hospital Memphis, Tennessee, USA. He earned a postgraduate degree in Clinical Microbiology and Virology 2005 and an M.D. 2001 from the University of Insubria Varese, Italy. He has authored several articles in various international scientific journals and currently serves as a peerreviewer for “HIV/AIDS – Research and Palliative Care”, “Clinical Epidemiology”, “International Journal of Interferon, Cytokine and Mediator Research”, “Infection and Drug Resistance”, “Virus adaptation and Treatment” and “Drug Design, Development and Therapy”.

HIV vaccine development Induction of broadly neutralizing antibodies to HIV Determination of correlates of protective immunity to HIV Biology of the generation and maintenance of protective immunological memory after infection or upon vaccination. Development of functional assays for the evaluation at a single-cell level of B-cell responses to vaccinations, infections and in vitro stimulation Epidemiology and characterization of bacterial resistance determinants (past).

Sabine Wicker Ph.D is an Assistant professor of occupational medicine, Head of the works doctor service, Klinikum der Johann Wolfgang Goethe University,  Theodor SternKai 7 60590 Frankfurt, Germany.

Occupational medicine

Environmental epidemiology, Toxicology

Elzein Mariam obtained her BSc in Environmental Health 1993 and her MSc in Public Health 1995 from the American University of Beirut. She earned a PhD 2003 in Epidemiology Biostatistics and Occupational Health from McGill University. She then held a research associate position 2003-2005 at the Sainte Justine Hospital under the direction of Dr Claire Infante Rivard. She is now at the final stages of completing her postdoctoral training at the INRS Institut Armand Frappier University du Qubec under the direction of Dr Marie Claude Rousseau Upon completion she is expected to pursue her research career as a research associate in this institution 7 publications abstract reviewer for Canadian Public Health Association official and unofficial reviewer for BioMed Central Cancer Letters Pediatric Allergy and Immunology Allergologia et Immunopathologia

Epidemiology of occupational asthma, Epidemiology of childhood asthma and diabetes Immunology-related circumstances and chronic diseases, Cancer epidemiology, Occupational exposure assessment for epidemiology, Use of administrative databases for epidemiology, Childhood vaccinations, Meta-analyses

Shiladitya DasSarma is a Professor in the Department of Microbiology & Immunology in the University of Maryland School of Medicine and in the Institute of Marine & Environmental Technology, University System of Maryland, Baltimore, Maryland.  He received his PhD from the Massachusetts Institute of Technology and did his postdoctoral training in the Massachusetts General Hospital, Harvard Medical School.

Use of biological nanoparticles for antigen delivery and vaccines.  Novel approaches to the development of vaccines and vaccination.

Dr. Eung Jun Im received his DPhil from Oxford University as a British Chevening Scholar and is currently working at the Beth Israel Deaconess Medical Center in Boston. He has extensive experience constructing DNA, bacterial and viral vaccines.

HIV vaccine and mucosal immunology

Dr. Xi Yang joined the United States Food and Drug Administration (FDA) in 2009 working with Dr. William Salminen in the Division of Systems Biology at the National Center for Toxicological Research (NCTR).  Her primary research focus is in improving drug safety by identifying new biomarkers of liver injury and their qualification, human genetic polymorphisms and smoking related human disease. At NCTR, Dr. Yang designed an innovative method for collecting, processing, and analyzing urinary microRNAs and found that urinary microRNAs may be superior to traditional biomarkers in predicting drug-induced liver injury.  Prior to her work at NCTR, she obtained a Ph.D. degree in Genetics from Pennsylvania State University.

Dr. Aref graduated from faculty of Veterinary Medicine at Assiut University in 1994. He had got his master degree in internal veterinary medicine from the same faculty in 1998 with special emphasis on neonatal calf diarrhea with special reference to acid base balance and rehydration therapy. He has got Ph.D. in Large Animal Clinical Sciences from College of Veterinary Medicine at Michigan State University, US in 2008 focusing on constructing a highly immunogenic heat stable enterotoxin (STa) of enterotoxigenic Escherichia coli (ETEC) strains. The outcome of his Ph.D. work has been filed for a patent in USA. Dr. Arefprime&;s scholarly work is geared towards enterotoxin-mediated diarrheal diseases and development ST-based ETEC vaccine. Dr. Aref is currently holding a senior lecturer of Animal Medicine at Assiut University-Egypt.

He currently working as a professor of Infectious Diseases & Pathology Department at university of florida, USA

1. To study the properties of novel adjuvants that induce the activation of mucosal DCs
2. To elucidate cellular and molecular mechanisms that rebalance overt inflammatory immune responses induced by pathogenic commensal bacteria within the mucosal side

Dr. Namita Rout is a Research Fellow in Medicine at Harvard Medical School. She received her Ph.D. degree in virology from Anna University, India in 2008. She is a pioneer of DNA vaccination in an invertebrate species and one of the first few researchers to report memory-like response of the innate immune system.

Pathogenesis of simian immunodeficiency virus (SIV), viral persistence, virus-host interaction leading to nonpathogenic SIV infection in natural hosts, innate immune responses to viruses and vaccine development.